<bill session="116" type="h" number="3327" updated="2022-11-01T13:51:04Z">
  <state datetime="2019-06-18">REFERRED</state>
  <status>
    <introduced datetime="2019-06-18"/>
  </status>
  <introduced datetime="2019-06-18"/>
  <titles>
    <title type="display">Drug Price Transparency for Medicare Patients Act of 2019</title>
    <title type="official" as="introduced">To amend title XI of the Social Security Act to require that direct-to-consumer television advertisements for prescription drugs and biological products include the list price of such drugs and products, and for other purposes.</title>
    <title type="short" as="introduced">Drug Price Transparency for Medicare Patients Act of 2019</title>
  </titles>
  <sponsor bioguide_id="R000607"/>
  <cosponsors>
    <cosponsor bioguide_id="L000563" joined="2019-07-10"/>
  </cosponsors>
  <actions>
    <action datetime="2019-06-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-06-18" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-06-18">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2019-06-19">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Government information and archives"/>
    <term name="Inflation and prices"/>
    <term name="Marketing and advertising"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-07-03T15:50:23Z" status="Introduced in House">Drug Price Transparency for Medicare Patients Act of 2019

This bill provides statutory authority for the Centers for Medicare &amp; Medicaid Services rule titled "Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency," published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.</summary>
</bill>
